Established Translational CRO ERBC is an established translational CRO with a fifty year track record, offering in vitro and in vivo translational models, regulatory pre IND package, and consultancy to help biopharma and chemical firms de-risk early R&D.

Three Rs Focus Prioritizes alternatives to animal testing in study design, embedding sustainability and ethics, appealing to clients seeking humane and efficient preclinical solutions.

Industry Engagement Active involvement in major toxicology and pharmacology conferences such as EUROTOX, SOT, FELASA and Oncostart, along with LabWare LIMS education sessions, demonstrates access to decision makers and ongoing business development.

Digital Lab Enablement A modern tech stack including Sage X3, Google Workspace, PWA and cloud security, plus focus on LIMS integration shows ERBC aims to deliver data driven, compliant preclinical programs and smoother regulatory submissions.

Growth Opportunity Mid sized CRO with revenue in the one to ten million USD range and a strong client focus offers room to scale through expanded translational services, pre IND work and broader biopharma collaborations.